BackEVOTEC ORD SHS Overview

EVOTEC ORD SHS Total Current Liabilities

EVOTEC ORD SHS's total current liabilities is $310M.

Get informed when a big investor buys or sells

+ Follow
Total Current Liabilities
$312.46M
↓ 18.46% YoYΔ $-70.72M vs prior year quarter

Peer trimmed avg / median

Loading

EVOTEC ORD SHS Total Current Liabilities History

Loading

EVOTEC ORD SHS vs. peers: Total Current Liabilities Comparison

Loading

EVOTEC ORD SHS Total Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

EVOTEC ORD SHS (EVOTF) FAQ

EVOTEC ORD SHS (EVOTF) currently reports a total current liabilities of $310M as of June 2026. That compares with $380M in the prior-year period — down 18.5% year over year. Use the charts on this page to explore EVOTEC ORD SHS's total current liabilities history and peer comparisons.

EVOTEC ORD SHS's total current liabilities decreased from $380M to $310M — a 18.5% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

EVOTEC ORD SHS reported $310M in total current liabilities as of June 2026. That compares with $380M in the prior-year period — down 18.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total current liabilities of $310M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for EVOTEC ORD SHS, and consider following EVOTF for alerts when major investors trade the stock.

EVOTEC ORD SHS is classified in the Healthcare sector. On total current liabilities, it currently shows $310M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing EVOTF with unrelated industries.